Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) EPS (Basic): 2020-2025

Historic EPS (Basic) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$0.18.

  • Maravai Lifesciences Holdings' EPS (Basic) rose 73.53% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.84, marking a year-over-year increase of 48.78%. This contributed to the annual value of -$1.05 for FY2024, which is 16.67% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' EPS (Basic) is -$0.18, which was up 33.33% from -$0.27 recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year EPS (Basic) high stood at $0.54 for Q2 2022, and its period low was -$0.80 during Q4 2023.
  • For the 3-year period, Maravai Lifesciences Holdings' EPS (Basic) averaged around -$0.24, with its median value being -$0.18 (2025).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' EPS (Basic) skyrocketed by 7,767.47% in 2021 and then slumped by 1,575.01% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' EPS (Basic) (Quarterly) stood at $0.43 in 2021, then crashed by 34.88% to $0.28 in 2022, then tumbled by 385.71% to -$0.80 in 2023, then skyrocketed by 77.50% to -$0.18 in 2024, then surged by 73.53% to -$0.18 in 2025.
  • Its EPS (Basic) stands at -$0.18 for Q3 2025, versus -$0.27 for Q2 2025 and -$0.21 for Q1 2025.